CA2661705A1 - Method of diagnosis - Google Patents
Method of diagnosis Download PDFInfo
- Publication number
- CA2661705A1 CA2661705A1 CA002661705A CA2661705A CA2661705A1 CA 2661705 A1 CA2661705 A1 CA 2661705A1 CA 002661705 A CA002661705 A CA 002661705A CA 2661705 A CA2661705 A CA 2661705A CA 2661705 A1 CA2661705 A1 CA 2661705A1
- Authority
- CA
- Canada
- Prior art keywords
- expression
- set out
- genes
- scar
- keloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0617117.7 | 2006-08-31 | ||
| GBGB0617117.7A GB0617117D0 (en) | 2006-08-31 | 2006-08-31 | Method of diagnosis |
| PCT/GB2007/003232 WO2008025963A2 (en) | 2006-08-31 | 2007-08-28 | Method of diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2661705A1 true CA2661705A1 (en) | 2008-03-06 |
Family
ID=37137074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002661705A Abandoned CA2661705A1 (en) | 2006-08-31 | 2007-08-28 | Method of diagnosis |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090280995A1 (https=) |
| EP (1) | EP2059612A2 (https=) |
| JP (1) | JP2010502940A (https=) |
| AU (1) | AU2007291076A1 (https=) |
| CA (1) | CA2661705A1 (https=) |
| GB (1) | GB0617117D0 (https=) |
| WO (1) | WO2008025963A2 (https=) |
| ZA (1) | ZA200900639B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015120350A2 (en) * | 2014-02-07 | 2015-08-13 | Effector Therapeutics, Inc. | Compositions and methods for treating fibrotic disease |
| WO2016011143A1 (en) * | 2014-07-15 | 2016-01-21 | Temple University Of The Commonwealth System Of Higher Education | Stabilized peptide fragments from redoxin proteins as cancer biomarkers |
| KR101667900B1 (ko) * | 2016-01-15 | 2016-10-21 | 테고사이언스 (주) | 켈로이드성 피부 또는 켈로이드 흉터 진단용 바이오마커 단백질 및 이의 이용 |
| CN115616215B (zh) * | 2021-07-13 | 2026-03-06 | 上海交通大学医学院附属第九人民医院 | 一种瘢痕诊断试剂及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040029114A1 (en) * | 2001-01-24 | 2004-02-12 | Eos Technology, Inc. | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| JP4344165B2 (ja) * | 2003-04-21 | 2009-10-14 | 第一三共株式会社 | ケロイドの診断方法 |
-
2006
- 2006-08-31 GB GBGB0617117.7A patent/GB0617117D0/en not_active Ceased
-
2007
- 2007-08-28 US US12/439,301 patent/US20090280995A1/en not_active Abandoned
- 2007-08-28 ZA ZA200900639A patent/ZA200900639B/xx unknown
- 2007-08-28 WO PCT/GB2007/003232 patent/WO2008025963A2/en not_active Ceased
- 2007-08-28 AU AU2007291076A patent/AU2007291076A1/en not_active Abandoned
- 2007-08-28 CA CA002661705A patent/CA2661705A1/en not_active Abandoned
- 2007-08-28 JP JP2009526165A patent/JP2010502940A/ja not_active Abandoned
- 2007-08-28 EP EP07789319A patent/EP2059612A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB0617117D0 (en) | 2006-10-11 |
| JP2010502940A (ja) | 2010-01-28 |
| EP2059612A2 (en) | 2009-05-20 |
| AU2007291076A1 (en) | 2008-03-06 |
| WO2008025963A3 (en) | 2008-05-02 |
| ZA200900639B (en) | 2010-05-26 |
| WO2008025963A2 (en) | 2008-03-06 |
| US20090280995A1 (en) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2500436B1 (en) | Method, probe and kit for DNA in situ hybridation and use thereof | |
| CA2560444C (en) | Tape stripping methods for analysis of skin disease and pathological skin state | |
| EP2576825B1 (en) | Methods for assessing endometrium receptivity of a patient | |
| US9790552B2 (en) | Detection of organ rejection | |
| CA2438030A1 (en) | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | |
| CA2597030A1 (en) | Vagal afferent neurons as targets for treatment | |
| CA2661705A1 (en) | Method of diagnosis | |
| AU2003233743A1 (en) | Identification of specific marker genes and use thereof | |
| CA2405431A1 (en) | Gene expression profiles in esophageal tissue | |
| MXPA05011404A (es) | Conservacion del arn en una muestra biologica. | |
| Helip-Wooley et al. | Sucrose-induced vacuolation results in increased expression of cholesterol biosynthesis and lysosomal genes | |
| CA2661699A1 (en) | Method of diagnosis | |
| Shima et al. | Alterations in gene expression associated with changes in the state of endothelial differentiation | |
| EP1277842A2 (en) | Method for quantifying nucleic acid by cell counting | |
| Yan et al. | Trisomy 8 and monosomy 7 detected in bone marrow using primed in situ labeling, fluorescence in situ hybridization, and conventional cytogenetic analyses.: A study of 54 cases with hematological disorders | |
| CN108624678A (zh) | 一种用于子痫前期诊治的生物标志物 | |
| KR20190017698A (ko) | 결핵 진단용 키트 및 이를 이용한 결핵의 진단방법 | |
| CA2433436A1 (en) | Gene expression profiles associated with osteoblast differentiation | |
| US20100184610A1 (en) | Method of prognosis | |
| CN108728531A (zh) | 生物标志物cbx8在子痫前期诊治中的应用 | |
| CN108624677A (zh) | Npl在子痫前期诊断和治疗中的应用 | |
| CN103194532A (zh) | Wdhd1基因的用途 | |
| CN108624674A (zh) | Krt73作为分子靶标在帕金森诊治中的应用 | |
| CN108588212A (zh) | 一种与子痫前期发生发展相关的基因及其应用 | |
| CN108642132A (zh) | 探针稳定剂和bcr-abl基因融合检测试剂盒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |